About the Authors
- Rachel Bryan
-
* E-mail: r.bryan@swansea.ac.uk
Affiliation Swansea University, Swansea, Wales, United Kingdom
- Jeffrey K. Aronson
-
Affiliation Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
- Pius ten Hacken
-
Affiliation Institute for Translation Studies, University of Innsbruck, Innsbruck, Austria
- Alison Williams
-
Affiliation Swansea University, Swansea, Wales, United Kingdom
- Sue Jordan
-
Affiliation Swansea University, Swansea, Wales, United Kingdom
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have no competing interests. JKA is Chairman of the British Pharmacopoeia Commission's Expert Advisory Group on Drug Nomenclature, President Emeritus and an Honorary Fellow of the British Pharmacological Society, a member of a Technology Appraisal Committee of the UK's National Institute for Health and Care Excellence (NICE), Editor of Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, Editor of the Side Effects of Drugs Annuals, and a member of the Editorial Advisory Board of the Adverse Drug Reactions Bulletin. The views expressed in this article are not necessarily shared by these institutions or others associated with them. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RB SJ. Analyzed the data: RB. Wrote the paper: RB. Manuscript comments, suggestions and amendments in the following order of contribution from most to least: SJ JKA PtH AW.